LEXARIA BIOSCIENCE CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.08 USD | 0.00% |
|
-12.99% | +146.40% |
| May. 08 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
| Apr. 16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LEXARIA BIOSCIENCE CORP. | Other Pharmaceuticals | 0.00% | -12.99% | +146.40% | +324.94% | -89.42% | 39.69M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- LEXX Stock
- Charts Lexaria Bioscience Corp.
- Comparison Chart
